Review on the association of Group B Streptococcus capsular antibody and protection against invasive disease in infants (Q38253017)

1 September 2017

1 reference

title

Review on the association of Group B Streptococcus capsular antibody and protection against invasive disease in infants (English)

1 reference

1 September 2017

1 reference

5

Shabir A Madhi

1 reference

1 September 2017

Ziyaad Dangor

1

1 reference

1 September 2017

Gaurav Kwatra

series ordinal

2

1 reference

1 September 2017

Alane Izu

series ordinal

3

1 reference

1 September 2017

Sanjay G Lala

series ordinal

4

1 reference

1 September 2017

22 September 2014

1 reference

Expert Review of Vaccines

1 September 2017

1 reference

1 September 2017

14

1 reference

1 September 2017

1

1 reference

1 September 2017

135-149

1 reference

The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008.

1 September 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.953939

Bacterial meningitis in the United States, 1998-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.953939

Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.953939

Epidemiology of Group B Streptococcus in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.953939

Preventing the broad spectrum of perinatal morbidity and mortality through group B streptococcal vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.953939

Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.953939

Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.953939

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.953939

Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.953939

Quantitative determination of antibody to capsular polysaccharide in infection with type III strains of group B Streptococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.953939

Immunological investigation of infants with septicemia or meningitis due to group B Streptococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.953939

Prevalence of type-specific group B streptococcal antibody in pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.953939

Human IgG antibody to group b Streptococcus type III: comparison of protective levels in a murine model with levels in infected human neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.953939

Prevalence of anti-group B streptococcal type III capsular IgG antibodies in the United Kingdom and an analysis of their specific IgG subclasses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.953939

Maternal antibody at delivery protects neonates from early onset group B streptococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.953939

Seroepidemiology of group B Streptococcus type II antibody specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.953939

Development of IgM antibody to group B Streptococcus type III in human infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.953939

Type-specific polysaccharide antigens of group B streptococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.953939

Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.953939

Mouse Protection Test for Group B Streptococcus Type III

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.953939

Cellular and humoral immune response to group B streptococci.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.953939

Assessment of group B streptococcal opsonins in human and rabbit serum by neutrophil chemiluminescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.953939

Persistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.953939

Immunogenicity and physico-chemical characterisation of a candidate conjugate vaccine against group B streptococcus serotypes Ia, Ib and III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.953939

Antibodies to Capsular Polysaccharides of Group BStreptococcusin Pregnant Canadian Women: Relationship to Colonization Status and Infection in the Neonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.953939

10.1586/14760584.2014.953939

21 January 2018

Identifiers

DOI

1 reference

1 September 2017

1 reference